Update of GBS screening guidelines
Metadata[+] Show full item record
Implementation of universal screening of pregnant women at 35 to 37 weeks' gestation significantly decreases early-onset group B streptococcal disease in neonates. Emerging evidence in the management of pregnant women with unknown group B Streptococcus (GBS) status, women with preterm labor, and women with preterm premature rupture of membranes (pPROM) suggests that morbidity and mortality could be reduced further if intrapartum screening methods were implemented.
Evidence Based Practice 14(2): 01-03.